ArticleTechnology in cancer research & treatment

Tolerance and Pharmacokinetics of Recombinant Human Endostatin Administered as Single-Dose or Multiple-Dose Infusions in Patients With Advanced Solid Tumors: A Phase I Clinical Trial.

Xu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.